[The NMD escape mechanism and its application in disease therapy]

Miao Miao Cheng1, Yan Yan Cao1

  • 1Department of Medical Genetics, Capital Institute of Pediatrics, Beijing 100020, China.

Yi Chuan = Hereditas
|April 22, 2020
PubMed

Insights

Nonsense-mediated mRNA decay (NMD) degrades faulty mRNA. NMD escape, where faulty mRNAs evade degradation, offers new therapeutic strategies for genetic diseases by restoring protein function.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Nonsense-mediated mRNA decay (NMD) is a crucial cellular quality control mechanism that eliminates aberrant messenger RNAs (mRNAs) containing premature termination codons (PTCs).
  • NMD prevents the production of potentially harmful truncated proteins.
  • Recent findings reveal that certain PTCs can evade NMD, a phenomenon termed 'NMD escape', which is observed in various diseases.

Purpose of the Study:

  • To review the fundamental mechanisms of NMD.
  • To explore the emerging concept of NMD escape and its underlying molecular hypotheses.
  • To discuss the therapeutic implications and advancements in utilizing NMD escape for treating genetic disorders.

Main Methods:

  • Literature review of NMD pathways and NMD escape mechanisms.
  • Analysis of current research on therapeutic strategies targeting NMD escape.
  • Synthesis of existing knowledge on PTC read-through and translation reinitiation.

Main Results:

  • Two primary hypotheses for NMD escape are PTC read-through (producing full-length proteins) and translation reinitiation (producing N-terminal truncated proteins).
  • Therapeutic strategies leveraging PTC read-through are increasingly successful in treating diseases caused by nonsense mutations.
  • Understanding NMD escape mechanisms is critical for developing novel treatments.

Conclusions:

  • NMD escape represents a significant biological process with considerable therapeutic potential.
  • Targeting NMD escape pathways, particularly PTC read-through, offers promising avenues for treating genetic diseases.
  • Further research into NMD escape mechanisms will accelerate the development of effective therapies for nonsense variation-associated conditions.

Related Concept Videos

Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.5K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

3.2K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.5K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K